Estrogen receptor regulates hormone-induced growth arrest in a luminal A like breast cancer model

bioRxiv

Authors: Haddon, Lacey; Hu, Sunny; Jabbari, Hosna; Loney, Brittney; Lichtensztejn, Zelda-Saidman; Fahlman, Richard; Hitt, Mary; McManus, Kirk; Dabbs, Kelly; Mackey, John;
PDF

Abstract

Estrogen receptor positive (ER+) breast cancer has been divided into two subtypes, luminal A and luminal B, which differ in their ER expression and response to hormone therapy. The absence of luminal A cell lines means the extensive amount of in vitro work studying the response to hormones in ER+ breast cancers is biased for the luminal B subtype. We have developed a luminal A like cell model by increasing the ER expression in the MCF-7 cell line. Our results show that increased ER expression promotes an anti-proliferative response to estrogen through regulation of genes involved in the G1/S-phase transition of the cell cycle. Furthermore, increased ER expression increases ER-DNA binding in the absence of estrogen and regulates basal gene transcription by promoting DNA looping. These results provide novel evidence that the characteristic increased ER expression of luminal A tumors may promote a novel chromatin configuration that enables growth of these tumors in the absence of estrogen and enables gene repression in the presence of hormones.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy